Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems<\/p>\n
Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows<\/p>\n
Clarivate Plc\u00a0(NYSE:\u00a0CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate\u2019s proprietary regulatory intelligence with Claude\u2019s AI reasoning capabilities. The collaboration gives biopharma, biotech, medtech and clinical research organizations intelligent, context-aware access to authoritative regulatory data within the AI workflows they already use.<\/p>\n
Cortellis Regulatory Intelligence\u00a0(CRI) data and insights will be integrated into Anthropic\u2019s Claude through the open Model Context Protocol (MCP). This MCP-enabled connection embeds authoritative regulatory content directly into customer workflows- combining Claude\u2019s natural language understanding and reasoning with Clarivate\u2019s industry-validated sources to deliver accurate, referenced answers that support faster, more confident regulatory decision-making.<\/p>\n
The new CRI MCP provides regulatory affairs, pharmacovigilance and life sciences teams with direct access to Clarivate regulatory intelligence, delivering accurate, referenced answers grounded in industry-validated sources. The CRI MCP is available to customers of Clarivate CRI and Claude.<\/p>\n
Through this integration, Clarivate is extending its regulatory intelligence into the AI environments customers already use, expanding the ecosystems that inform critical decisions. With this connection to Claude, customers can build agents that combine CRI with internal data and approved external sources, enabling regulatory intelligence to work alongside internal data to monitor changes and support decision-making.<\/p>\n
Henry Levy, President, Life Sciences & Healthcare, Clarivate, said:\u00a0\u201cThis advances our strategy to extend Clarivate intelligence into AI ecosystems where critical decisions are made. By bringing Cortellis Regulatory Intelligence into Claude, we are expanding the reach of our trusted regulatory insights. This enables Clarivate life sciences customers to access authoritative content within their AI workflows and make more informed decisions that help bring safer, more effective therapies to patients.\u201d<\/p>\n
Building on the recent\u00a0launch of the CRI AI Assistant, the integration expands anticipatory intelligence and intelligent automation across regulatory workflows. To learn more about\u00a0Cortellis Regulatory Intelligence, visit:\u00a0Cortellis Regulatory Intelligence.<\/p>\n
The post Clarivate Expands Regulatory Intelligence Access Within Claude first appeared on AI-Tech Park.<\/p>\n","protected":false},"excerpt":{"rendered":"
Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows Clarivate Plc\u00a0(NYSE:\u00a0CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate\u2019s proprietary regulatory intelligence with Claude\u2019s AI reasoning capabilities. The collaboration gives biopharma,…<\/p>\n
The post Clarivate Expands Regulatory Intelligence Access Within Claude<\/a> first appeared on AI-Tech Park<\/a>.<\/p>\n<\/div>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-container-style":"default","site-container-layout":"default","site-sidebar-layout":"default","disable-article-header":"default","disable-site-header":"default","disable-site-footer":"default","disable-content-area-spacing":"default","footnotes":""},"categories":[4,1],"tags":[3],"class_list":["post-1838","post","type-post","status-publish","format-standard","hentry","category-ai","category-ai-and-ml","tag-ai"],"yoast_head":"\n